Skip to main content

UBS Group AG

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in FDMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,413,750
+$1,941,654 QoQ
Shares Held
256,673
+62.3% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 158 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in FDMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. FDMT ranks #172 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FDMT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,413,750 256,673
2026-03-31 $1,472,096 158,120
2025-12-31 $1,734,690 231,292
2025-09-30 $824,681 94,900
2025-06-30 $358,084 96,519
2025-03-31 $763,717 236,445
2024-12-31 $543,430 97,564
2024-09-30 $867,922 80,289
2024-06-30 $1,409,267 67,140
2024-03-31 $11,921,692 374,190
2023-12-31 $1,743,392 86,051
2023-09-30 $571,538 44,897
2023-06-30 $973,068 53,850
2023-03-31 $900,738 52,399
2022-12-31 $904,567 40,728
2022-06-30 $244 35
2022-03-31 $1,061,936 70,234
2021-12-31 $1,521,538 69,350
2021-09-30 $33,874 1,256
2021-03-31 $893,280 20,592